Screening for safe harbor sites in the genome may improve the safety of gene therapy.
References
Papapetrou, E.P. et al. Nat. Biotechnol. 29, 73–78 (2011).
Felice, B. et al. PLoS ONE 4, e4571 (2009).
Cattoglio, C. et al. Blood published online, doi:10.1182/blood-2010–05–283523 (23 September 2010).
Cavazzana-Calvo, M. et al. Nature 467, 318–322 (2010).
Hockemeyer, D. et al. Nat. Biotechnol. 27, 851–857 (2009).
Perez, E.E. et al. Nat. Biotechnol. 26, 808–816 (2008).
DeKelver, R.C. et al. Genome Res. 20, 1133–1142 (2010).
Henckaerts, E. et al. Proc. Natl. Acad. Sci. USA 106, 7571–7576 (2009).
Takahashi, K. & Yamanaka, S. Cell 126, 663–676 (2006).
Hanna, J. et al. Science 318, 1920–1923 (2007).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Williams, D., Thrasher, A. Out of harm's way. Nat Biotechnol 29, 41–42 (2011). https://doi.org/10.1038/nbt.1750
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt.1750
- Springer Nature America, Inc.